• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09203095190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/28/2020
Event Type  malfunction  
Manufacturer Narrative
The reporter also mentioned they were having issues with results from pooled patient material used as a negative quality control.With reagent lot number 499300, results were non-reactive, but with reagent lot 507260, the results were reactive.Pooled patient material used as a positive control also showed an increase in values with lot 507260.Calibration signals recovered within expected ranges.The pooled patient material used as negative control and complained patient sample recovered values near the cutoff index of the assay (1.00).The investigation determined that the sensitivity and specificity claims are met.A general reagent issue can be excluded.No product problem found.Per product labeling, "a negative test result does not completely rule out the possibility of an infection with sars-cov-2.Serum or plasma samples from the very early (pre-seroconversion) phase can yield negative findings.Therefore, this test cannot be used to diagnose an acute infection." this event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with two lot numbers of the elecsys anti-sars-cov-2 assay on the cobas 6000 e 601 module.It is not known which result was considered to be correct.The patient sample was tested using reagent lot 499300, resulting with a value of 0.974 coi (non-reactive).This value was reported outside of the laboratory to the patient.The patient sample was tested using reagent lot 507260 on (b)(6) 2020, resulting with a value of 1.34 coi (reactive).The patient sample was repeated using reagent lot 507260 on (b)(6) 2020, resulting with a value of 1.37 coi (reactive).The e 601 analyzer serial number is (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key10593128
MDR Text Key208970138
Report Number1823260-2020-02378
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeMX
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number09203095190
Device Lot Number499300, 507260
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/07/2020
Initial Date FDA Received09/28/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-